Identification of Phase Separation in Solid Dispersions of Itraconazole and Eudragit® E100 Using Microthermal Analysis

AbstractPurpose. To evaluate the phase separation in itraconazole/Eudragit® E100 solid dispersions prepared by hot-stage extrusion. Methods. Extrudates were prepared using a corotating twin-screw extruder at 180°C. Micro-TA was used to evaluate the phase separation, where the AFM mode is used to visualize the different phases and local thermal analysis (LTA) to characterize the different phases Results. Itraconazole formed a homogeneous mixture with Eudragit® E100 with drug concentrations up to approximately 20%. Above this concentration, phase separation was observed. MTDSC revealed two Tgs and the mesophase of free glassy itraconazole. Performing micro-TA on the surface of these dispersions indicated an increase in sample roughness in the z-axis piezo signal, which could be an indication of free glassy itraconazole. However, thermal conductivity did not reveal differences between separate phases. Performing LTA, where only a small area (20 × 20 μm) is heated, showed two separate and mixed phases of itraconazole and Eudragit® E100. Tip penetration in itraconazole and Eudragit® E100 occurred at 332K and 383K respectively. The difference in tip penetration was explained in terms of the difference in fragility. Conclusion. Micro-TA makes it possible to characterize separate phases of itraconazole and Eudragit® E100, thereby confirming the MTDSC results on phase separation.

[1]  P. Royall,et al.  An investigation into the use of micro-thermal analysis for the solid state characterisation of an HPMC tablet formulation. , 1999, International journal of pharmaceutics.

[2]  R. Androsch,et al.  The Principles of Micro-Thermal Analysis and its Application to the Study of Macromolecules , 2000 .

[3]  D. Craig,et al.  The mechanisms of drug release from solid dispersions in water-soluble polymers. , 2002, International journal of pharmaceutics.

[4]  J. Dressman,et al.  Thermal Properties of Hot-Stage Extrudates of Itraconazole and Eudragit E100. Phase separation and polymorphism , 2002 .

[5]  J. Crison,et al.  A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability , 1995, Pharmaceutical Research.

[6]  S. Clissold,et al.  Itraconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in superficial and systemic mycoses. , 1989, Drugs.

[7]  P. Royall,et al.  Pharmaceutical applications of micro-thermal analysis. , 2002, Journal of pharmaceutical sciences.

[8]  T. Rades,et al.  Characterization of glass solutions of poorly water‐soluble drugs produced by melt extrusion with hydrophilic amorphous polymers , 2001, The Journal of pharmacy and pharmacology.

[9]  George Zografi,et al.  The use of thermal methods for predicting glass-former fragility , 2001 .

[10]  J. M. Barton Dependence of polymer glass transition temperatures on heating rate , 1969 .

[11]  Koen Binnemans,et al.  Investigation of thermal properties of glassy itraconazole: identification of a monotropic mesophase , 2001 .

[12]  Bruno C. Hancock,et al.  A Pragmatic Test of a Simple Calorimetric Method for Determining the Fragility of Some Amorphous Pharmaceutical Materials , 1998, Pharmaceutical Research.

[13]  P. Royall,et al.  Identification of Crystalline and Amorphous Regions in Low Molecular Weight Materials Using Microthermal Analysis , 2001 .

[14]  H. Pollock,et al.  Localised thermal analysis of a packaging film , 1999 .